H1
Summary active Updated May 31, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Investors
Founders
About
H1 is a New York-based AI-powered healthcare-information platform that helps pharmaceutical, health-plan, health-system, and technology customers identify and engage the right physicians across critical clinical and commercial workflows, co-founded and led by CEO Ariel Katz 1234. H1 reports 85% of the top 20 pharma companies and 9 of the top 10 health plans as customers; recent CVS Health collaborations include a new AI model that substantially improved healthcare-provider directory accuracy 14. The $40M round announced May 28, 2026 was led by CVS Health Ventures (Partner Justin Brock); other participants were not disclosed and the round follows multiple operational collaborations between H1 and CVS Health 1234. H1 turned cash-flow and EBITDA profitable in 2025 and is forecasting over 40% growth in 2026; the company was last valued at $750M in November 2021 when it raised a $100M round led by Altimeter Capital 2.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-05-28 | Growth | $40M | CVS Health Ventures | — 1234 |
What Investors Say
“CVS Health has a long-standing commitment to improving access to care and this collaboration represents another step in our mission to develop industry-leading solutions that simplify the healthcare experience.”
— Justin Brock, Partner, CVS Health Ventures 4
What Founders Say
“This collaboration with CVS Health Ventures further enables H1 to achieve its mission of connecting the world to the right doctor.”
— Ariel Katz, Co-Founder & CEO, H1 14
“I don’t worry about Claude ever doing what we do.”
— Ariel Katz, Co-Founder & CEO, H1, TechCrunch interview, May 28, 2026 2
Sources
-
GlobeNewsWire, “H1 Receives $40M Investment in Round Led by CVS Health Ventures,” May 28, 2026. Accessed June 2026. https://www.globenewswire.com/news-release/2026/05/28/3303059/0/en/h1-receives-40m-investment-in-round-led-by-cvs-health-ventures.html↩↩↩↩↩
-
TechCrunch, “H1 secures $40M from CVS, proving SaaS startups can still attract investment,” May 28, 2026. Accessed June 2026. https://techcrunch.com/2026/05/28/h1-secures-40m-from-cvs-proving-saas-startups-can-still-attract-investment/↩↩↩↩↩
-
Dealroom, “H1 raises $40M from CVS Health Ventures,” May 2026. Accessed May 2026. https://app.dealroom.co/news/note/h1-raises-40m-from-cvs-health-ventures↩↩↩
-
H1, “H1 Receives $40M Investment from CVS Health Ventures,” official press release, May 28, 2026. Accessed June 2026. https://h1.co/press/h1-receives-40m-investment-in-round-led-by-cvs-health-ventures/↩↩↩↩↩↩